Evidence map›Paper›PMID 23077065›Full record

ArticleThe Journal of neuroscience : the official journal of the Society for Neuroscience2012

The retinoblastoma protein is essential for survival of postmitotic neurons.

Matthew G Andrusiak, Renaud Vandenbosch, David S Park, Ruth S Slack

Open access · bronzeAbstract read
In one paragraph

Article in The Journal of neuroscience : the official journal of the Society for Neuroscience, 2012. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 28 papers.

0numbers the graph read from it
0cells of the map it votes in
28citing papers in PubMed
2.7field-weighted citation impact, top 9% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

28 citing papers in PubMed, 46 citations in OpenAlex.

  1. Article
  2. Review
  3. METTLing in Stem Cell and Cancer Biology.Stem cell reviews and reports · 2023
    Review
  4. Article
  5. Article
  6. Article
  7. Article
  8. Cell Cycle Proteins as Key Regulators of Postmitotic Cell Death.The Yale journal of biology and medicine · 2019
    Review
  9. Review
  10. Review
  11. Article
  12. RB: An essential player in adult neurogenesis.Neurogenesis (Austin, Tex.) · 2017
    Article
  13. Review
  14. Article
  15. Article
  16. Article
  17. RB in DNA repair.Oncotarget · 2015
    Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 1 institution in 1 country.

Matthew G AndrusiakDepartment of Cellular and Molecular Medicine, University of Ottawa, Ottawa, Ontario K1H 8M5, Canada.
Renaud Vandenbosch
David S Park
Ruth S Slack
University of Ottawa · CA

Funding

Canadian Institutes of Health Research
6 · The paper itself

Abstract

The retinoblastoma protein (Rb) family members are essential regulators of cell cycle progression, principally through regulation of the E2f transcription factors. Growing evidence indicates that abnormal cell cycle signals can participate in neuronal death. In this regard, the role of Rb (p105) itself has been controversial. Germline Rb deletion leads to massive neuronal loss, but initial reports argue that death is non-cell autonomous. To more definitively resolve this question, we generated acute murine knock-out models of Rb in terminally differentiated neurons in vitro and in vivo. Surprisingly, we report that acute inactivation of Rb in postmitotic neurons results in ectopic cell cycle protein expression and neuronal loss without concurrent induction of classical E2f-mediated apoptotic genes, such as Apaf1 or Puma. These results suggest that terminally differentiated neurons require Rb for continuous cell cycle repression and survival.

Indexed as

AnimalsCell DeathCells, CulturedCell SurvivalMiceMice, Inbred C57BLMice, KnockoutMitosisNeuronsRetinoblastoma ProteinRetinoblastoma Protein

Identifiers

PMID23077065
PMCPMC6621457
OpenAlexW1976838074

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.